Glucose Paracélsia (Glucose)

Glucose Paracélsia is indicated for several clinical situations where rapid carbohydrate supplementation or fluid replacement is required.

• Treatment of hypoglycemia in patients unable to take oral glucose.
• Intravenous fluid replacement for patients with low intravascular volume.
• Component of parenteral nutrition regimens to meet caloric needs.
• Support during surgical procedures to maintain blood glucose levels.
• Adjunct in emergency care when immediate energy source is needed.
• Use in pediatric patients for rapid correction of low blood glucose under medical supervision.
• Utilized in critical care settings to assist with hemodynamic stabilization when combined with other electrolytes.

Glucose Paracélsia may be associated with a range of adverse effects, most of which are related to the intravenous administration of a carbohydrate solution.

Common

• Transient hyperglycemia when administered in excess.
• Local irritation or pain at the infusion site.
• Mild electrolyte shifts, such as slight sodium or potassium changes.
• Nausea or vomiting if the solution is infused rapidly.
• Headache related to rapid changes in blood glucose concentration.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Volume overload causing pulmonary edema in susceptible patients.
• Allergic reactions ranging from urticaria to anaphylaxis.
• Hyperosmolar hyperglycemic state in patients with impaired insulin response.
• Metabolic acidosis secondary to excessive glucose metabolism.

When prescribing Glucose Paracélsia, clinicians should consider several precautionary measures to minimize risk and ensure appropriate use.

• Assess baseline blood glucose and adjust infusion rate to avoid hyperglycemia.
• Evaluate fluid status and cardiac function to prevent volume overload.
• Use caution in patients with renal impairment due to altered glucose handling.
• Monitor electrolytes, especially sodium and potassium, during and after infusion.
• Avoid rapid bolus administration; prefer controlled infusion to reduce osmotic effects.
• Consider pregnancy and lactation status; data are limited, so use only if clearly indicated.

Glucose Paracélsia can interact with other intravenous therapies; awareness of potential interactions helps maintain patient safety.

Avoid

• Co‑administration with high‑dose insulin infusions without glucose monitoring, which may precipitate severe hypoglycemia.
• Simultaneous infusion of hypertonic saline solutions that could exacerbate hypernatremia.

Use with caution

• Concurrent use with other carbohydrate‑containing fluids; adjust total glucose load to prevent hyperglycemia.
• Administration alongside diuretics that affect fluid balance; monitor volume status closely.
• Use with vasopressors that may alter peripheral perfusion; observe infusion site for signs of irritation.
• Interaction with potassium‑sparing agents may increase serum potassium; check levels regularly.